You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

SCRUBTEAM SURGICAL SPONGEBRUSH Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Scrubteam Surgical Spongebrush, and when can generic versions of Scrubteam Surgical Spongebrush launch?

Scrubteam Surgical Spongebrush is a drug marketed by 3M and is included in one NDA.

The generic ingredient in SCRUBTEAM SURGICAL SPONGEBRUSH is hexachlorophene. There are seven drug master file entries for this compound. Additional details are available on the hexachlorophene profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for SCRUBTEAM SURGICAL SPONGEBRUSH?
  • What are the global sales for SCRUBTEAM SURGICAL SPONGEBRUSH?
  • What is Average Wholesale Price for SCRUBTEAM SURGICAL SPONGEBRUSH?
Summary for SCRUBTEAM SURGICAL SPONGEBRUSH
Drug patent expirations by year for SCRUBTEAM SURGICAL SPONGEBRUSH

US Patents and Regulatory Information for SCRUBTEAM SURGICAL SPONGEBRUSH

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m SCRUBTEAM SURGICAL SPONGEBRUSH hexachlorophene SPONGE;TOPICAL 017413-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

SCRUBTEAM SURGICAL SPONGEBRUSH Market Analysis and Financial Projection Experimental

Surgical Sponges Market Dynamics and Financial Trajectory

The surgical sponges market, which includes products like the SCRUBTEAM SURGICAL SPONGEBRUSH, is experiencing significant growth driven by several key factors. Here’s a detailed look at the market dynamics and financial trajectory of this industry.

Market Size and Growth Projections

The global surgical sponges market is anticipated to grow substantially over the next few years. By 2029, the market is expected to reach a revenue of USD 1.19 billion, up from USD 0.81 billion in 2024, registering a Compound Annual Growth Rate (CAGR) of 7.9%[1].

Another projection indicates that the market will reach USD 3.7 billion by 2032, growing at a CAGR of 5.8% from 2023 to 2032[4].

Key Drivers of Market Growth

Increasing Number of Surgical Procedures

The rising number of surgical procedures globally is a primary driver of the surgical sponges market. This increase is attributed to the growing prevalence of chronic diseases and the aging population, which necessitate more frequent surgical interventions[2][4][5].

Advancements in Healthcare Infrastructure and Technology

Improvements in healthcare infrastructure, particularly in emerging markets, and advancements in surgical techniques have led to the adoption of sophisticated surgical methods. These advancements require high-quality surgical sponges, thereby driving market growth[2][4].

Innovations in Materials and Design

Advances in materials science have resulted in the development of newer surgical sponge materials with improved performance, such as increased absorbency, reduced linting, and enhanced visibility under imaging modalities like X-rays. These innovations are crucial for maintaining a sterile and efficient surgical environment[2][3].

Regional Market Dynamics

North America

North America currently holds the largest share of the surgical sponges market due to its well-established healthcare infrastructure, including advanced hospitals and surgical centers. The region's high procedural volumes and growing prevalence of persistent illnesses further drive the demand for surgical sponges[1][5].

Asia Pacific

The Asia Pacific region is projected to grow at the highest CAGR due to the increasing volume of surgeries, rising prevalence of chronic diseases, and an expanding geriatric population. This region accounts for a significant portion of global cases of diseases such as breast and cervical cancer, which require complex surgical procedures[1][2][5].

Segmentation and Market Share

By Type of Surgical Sponge

The market is segmented based on the type of surgical sponge, including laparotomy, nonwoven, X-ray-detectable, cotton gauze, and other types. Cotton gauze sponges and X-ray-detectable sponges are particularly in high demand due to their multifunctional and safety-enhancing features[1][4].

By Material

The market is also segmented by material, with cotton being the most popular due to its soft, hypoallergenic, and absorbent properties. Cotton sponges are expected to grow at the fastest rate during the projected period[1].

By End User

Hospitals and ambulatory surgery centers dominate the market share due to the high volume of surgical procedures performed in these settings. These institutions prioritize patient safety and infection control, driving the demand for high-quality surgical sponges[4][5].

Financial Trajectory

Revenue Projections

The global surgical sponges market is projected to reach USD 1.19 billion by 2029 from USD 0.81 billion in 2024, and USD 3.7 billion by 2032 from USD 2.2 billion in 2022. These projections indicate a steady and significant growth in revenue over the coming years[1][4].

CAGR and Growth Rate

The market is expected to grow at a CAGR of 7.9% from 2024 to 2029 and 5.8% from 2023 to 2032. These growth rates are driven by the increasing demand for surgical procedures and the advancements in healthcare infrastructure and technology[1][4].

Key Players and Market Strategies

Major players in the surgical sponges market include TEPHA INC., Medical Devices Business Services, Inc., W. L. Gore & Associates, Inc., Mölnlycke Health Care AB, and Boston Scientific Corporation. These companies are adopting strategies such as investments and agreements to expand their market share and meet the growing demand for surgical sponges[4].

Emerging Trends and Opportunities

Sustainability and Eco-Friendly Practices

There is a growing emphasis on sustainability, including eco-friendly packaging and lower carbon footprints in the surgical sponge market. This trend is expected to influence the development of new products and practices in the industry[3].

Antimicrobial Coatings

The use of antimicrobial coatings on surgical sponges is becoming more prevalent, driven by the need for improved infection control and surgical safety. These coatings reduce the risk of postoperative infections and are gaining preference among healthcare practitioners[3].

Patient-Specific Customization

Patient-specific sponge customization is gaining traction, offering individualized solutions for various surgical demands. This trend is expected to enhance patient outcomes and improve the efficiency of surgical procedures[3].

Challenges and Opportunities in Emerging Markets

Emerging markets offer significant growth opportunities for the surgical sponges market due to the expansion of healthcare infrastructure and the increasing number of surgical procedures. However, these markets also present challenges such as varying regulatory environments and the need for cost-effective solutions[1][4].

"The Asia Pacific region is projected to grow at the highest CAGR due to the increasing volume of surgeries, rising prevalence of chronic diseases, and an expanding geriatric population"[1].

Key Takeaways

  • The surgical sponges market is driven by the increasing number of surgical procedures, advancements in healthcare infrastructure, and innovations in materials and design.
  • North America currently dominates the market, but the Asia Pacific region is expected to grow at the highest CAGR.
  • Cotton gauze sponges and X-ray-detectable sponges are in high demand due to their safety and efficiency features.
  • Hospitals and ambulatory surgery centers are the primary end users, driving the demand for high-quality surgical sponges.
  • The market is expected to reach USD 1.19 billion by 2029 and USD 3.7 billion by 2032, with a significant CAGR.

Frequently Asked Questions

What are the primary drivers of the surgical sponges market?

The primary drivers include the increasing number of surgical procedures, advancements in healthcare infrastructure, and innovations in materials and design.

Which region is expected to grow at the highest CAGR in the surgical sponges market?

The Asia Pacific region is projected to grow at the highest CAGR due to the increasing volume of surgeries and the expanding geriatric population.

What types of surgical sponges are in high demand?

Cotton gauze sponges and X-ray-detectable sponges are in high demand due to their safety and efficiency features.

Who are the major end users of surgical sponges?

Hospitals and ambulatory surgery centers are the primary end users, driving the demand for high-quality surgical sponges.

What is the projected market size of the surgical sponges market by 2032?

The market is projected to reach USD 3.7 billion by 2032, growing at a CAGR of 5.8% from 2023 to 2032.

Sources:

  1. MarketsandMarkets - Surgical Sponges Market Size, Share & Trends [2029]
  2. Allied Market Research - Surgical Sponge Market Predicted to Reach $3.7 Billion by 2032
  3. Future Market Insights - Laparotomy Sponge Market Size, Share & Forecast - 2034
  4. Allied Market Research - Surgical Sponge Market Size, Share| Segments| Forecast- 2032
  5. Polaris Market Research - Surgical Sponges Market Trends Analysis | Industry Report, 2034

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.